Follow
SUGIN LAL Jabaris
SUGIN LAL Jabaris
Research Officer(Pharmacology), SiddhaCentral Research Institute
Verified email at gov.in
Title
Cited by
Cited by
Year
Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease
A Kodimuthali, SSL Jabaris, M Pal
Journal of medicinal chemistry 51 (18), 5471-5489, 2008
1782008
Preparation and evaluation of mesalamine collagen in situ rectal gel: A novel therapeutic approach for treating ulcerative colitis
SK Ramadass, S Perumal, SL Jabaris, B Madhan
European journal of pharmaceutical sciences 48 (1-2), 104-110, 2013
542013
Tumor targeting using polyamidoamine dendrimer–cisplatin nanoparticles functionalized with diglycolamic acid and herceptin
A Kesavan, P Ilaiyaraja, WS Beaula, VV Kumari, JS Lal, C Arunkumar, ...
European Journal of Pharmaceutics and Biopharmaceutics 96, 255-263, 2015
532015
Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats
SGSL Jabaris, H Sumathy, RS Kumar, S Narayanan, S Thanikachalam, ...
European Journal of Pharmacology 746, 138-147, 2015
492015
Is Mucormycosis an inevitable complication of Covid-19in India?
R Bhogireddy, V Krishnamurthy, S Sugin Lal Jabaris, CP Pullaiah, ...
The Brazilian Journal of Infectious Diseases 25 (3), 101597, 2021
482021
The current situation of COVID-19 in India
SSL Jabaris, V Ananthalakshmi
Brain, Behavior, & Immunity-Health 11, 100200, 2021
40*2021
Phosphodiesterase-4 inhibitors ameliorates cognitive deficits in deoxycorticosterone acetate induced hypertensive rats via cAMP/CREB signaling system
SSL Jabaris, H Sumathy, R Girish, S Narayanan, M Sugumar, CS Babu, ...
Brain research 1622, 279-291, 2015
352015
Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain
R Nirogi, P Jayarajan, R Abraham, D Shanmuganathan, MA Rasheed, ...
European journal of pharmacology 668 (1-2), 155-162, 2011
322011
Type I collagen and its daughter peptides for targeting mucosal healing in ulcerative colitis: A new treatment strategy
SK Ramadass, SL Jabaris, RK Perumal, VI HairulIslam, A Gopinath, ...
European Journal of Pharmaceutical Sciences 91, 216-224, 2016
272016
Neuropharmacological evaluation of Morinda citrifolia Linn fruits extract in animal models of obsessive-compulsive disorder
S Jeyabalan, L Bala, K Subramanian, SL Jabaris, M Sekar, LS Wong, ...
Frontiers in Pharmacology 13, 993927, 2022
172022
Roflumilast: a potential drug for the treatment of cognitive impairment?
LJS Sugin, A Murugesan, M Bindu, KN Sunil
Neuroscience Letters 736, 135281, 2020
142020
Potential effects of noni (Morinda citrifolia L.) fruits extract against obsessive-compulsive disorder in marble burying and nestlet shredding behavior mice models
S Jeyabalan, L Bala, K Subramanian, SL Jabaris, M Sekar, LS Wong, ...
Frontiers in Pharmacology 13, 993927, 2022
82022
Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19
SSL Jabaris, V Ranju
Pulmonary Pharmacology & Therapeutics 66, 101978, 2020
8*2020
Fabrication of novel bio-compatible cefixime nanoparticles using chitosan and Azadirachta indica fruit mucilage as natural polymers
HarikaBalya, Arun Radhakrishnan, Sugin LalJabaris, SaiGopal Dvr ...
Journal of Drug Delivery Science and Technology 66, 102750, 2021
62021
Kabasura Kudineer, a Siddha medicine against COVID-19 infection: scope and future perspective
SSL Jabaris, Venkataraman K
International Journal of Complementary & Alternative Medicine 14 (3), 173-174, 2021
52021
Recent preclinical study offers a promising clue: Role of Regulatory T cells as biomarkers in migraine
A Murugesan, SSL Jabaris
Immunology Letters 240, 9-11, 2021
42021
Molecular Docking Studies of Phytoconstituents Identified in Traditional Siddha Polyherbal Formulations Against Possible Targets of SARS-CoV-2
LK Selvaraj, G Thayumanavan, S Jeyabalan, SL Jabaris
Journal of Molecular Docking 1 (1), 15-24, 2021
12021
P4-257 SUVN-G1031, A NOVEL SELECTIVE H3 RECEPTOR ANTAGONIST IN ANIMAL MODELS OF COGNITIVE DEFICITS
P Jayarajan, D Shanmuganathan, SL Jabaris, MR Babu, K Baburao, ...
RECEPTOR 4, 257, 2011
12011
COVID-19, its Prevention and Treatment in the light of Ayush Medicines
SL Jabaris S, V Krishnamurthy, D Sankaramourthy
Pharmacological Research-Natural Products, 100040, 2024
2024
POORANA CHANDROTHAYA CHENTHURAM (PCC), A SIDDHA SYSTEM OF MEDICINE PROTECTS AGAINST SCOPOLAMINE‐INDUCED COGNITIVE IMPAIRMENTS IN EXPERIMENTAL RATS
SLJS George, CP Pullaiah, B Krishnamoorthy
Alzheimer's & Dementia 19, e076085, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20